The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

Presentation information

Oral Presentation

(E) Pharmaceutical Health Care and Sciences

[31-411-pm] Pharmacotherapies (Personalized therapies) 1

Sun. Mar 31, 2024 2:15 PM - 3:15 PM [Room 411] Conference Center 411 (4F)

Chair: Takigawa Masaki, Masayuki Tsujimoto

3:03 PM - 3:15 PM

[31-411-pm10] Measurement of serum Infliximab and Interleukin-6 concentrations predicts continuation of Infliximab treatment in patients with Rheumatoid Arthritis

○Sho Masui1,2,3, Miyuki Nakamura2,3, Akira Onishi4, Motomu Hashimoto4,5, Hideo Onizawa4, Takayuki Fujii4,6, Kosaku Murakami7, Koichi Murata4,6, Masao Tanaka4, Kotoko Yokoyama8, Noriko Iwamoto8, Takashi Shimada8, Kotaro Itohara2, Daiki Hira2, Shunsaku Nakagawa2, Satoshi Imai2, Takayuki Nakagawa2, Makoto Hayakari2, Shuichi Matsuda6, Akio Morinobu4,9, Tomohiro Terada2, Kazuo Matsubara2, Atsushi Yonezawa1,2,3 (1. Sch. Pharm. Sci., Keio Univ., 2. Dept. Pharm., Kyoto Univ. Hospital., 3. Grad. Sch. Pharm. Sci., Kyoto Univ., 4. Center for Rheumatic Diseases, Kyoto Univ. Hospital., 5. Dept. Clin. Immunol., Osaka Metro. Univ. Hospital., 6. Dept. Ortho. Surg., Kyoto Univ. Hospital., 7. Center for Cancer Immunotherapy and Immunobiology, Kyoto Univ. Hospital., 8. Shimadzu Corp., 9. Dept. Rheumatol. & Clin Immunol., Kyoto Univ. Hospital.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Password